Which has grown faster, BDX or MRNA?

Over the past five years, MRNA grew revenue faster — BDX at a 1.22% CAGR versus MRNA at 19.33%.

Does BDX or MRNA pay a bigger dividend?

BDX pays a dividend (2.00% yield), while MRNA has no payments in the available dividend history.

Is BDX or MRNA more profitable?

BDX runs the higher net margin — BDX at 4.52% versus MRNA at -141.43%.

How have BDX and MRNA total returns compared?

Over the past 5 years, BDX delivered 5.12% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Becton, Dickinson and Company (BDX) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Becton, Dickinson and Company and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

BDX

Becton, Dickinson and Company

$51.69B

$187.60HealthcareDelayed quote: Aug 19, 2026, 4:00 PM EDT

MRNA

Moderna, Inc.

$69.19B

$174.38HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — BDX vs MRNA

growth of $100 · dividends reinvested · last 8y

BDX +9.7% (+1.2%/yr)MRNA +837.5% (+32.3%/yr)MRNA compounded faster over this window

Log scale — wide-divergence pair

BDX MRNA

BDX vs MRNA: by the numbers

•MRNA is the larger company ($69.19B vs $51.69B market cap).
•BDX is profitable (4.52% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 1.22% CAGR).
•BDX pays a dividend (2.00% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BDX	MRNA
P/E ratio	56.51	N/A
Forward P/E	14.88	N/A
P/S ratio	2.48	30.99
P/B ratio	2.11	10.21
EV / EBITDA	12.30	N/A
FCF yield	5.05%	N/A

Profitability

Metric	BDX	MRNA
Gross margin	46.12%	55.35%
Operating margin	9.83%	-158.13%
Net margin	4.52%	-141.43%
ROE	3.85%	-46.61%
ROIC	3.72%	-39.16%

Dividends

Metric	BDX	MRNA
Dividend yield	2.00%	N/A
Payout ratio	64.09%	N/A

Growth (annualized)

Metric	BDX	MRNA
Revenue CAGR (5Y)	1.22%	19.33%
EPS CAGR (5Y)	16.26%	N/A
FCF CAGR (5Y)	-9.10%	N/A
Total return CAGR (5Y)	1.53%	-14.22%

Frequently asked

Which has grown faster, BDX or MRNA?: Over the past five years, MRNA grew revenue faster — BDX at a 1.22% CAGR versus MRNA at 19.33%.
Does BDX or MRNA pay a bigger dividend?: BDX pays a dividend (2.00% yield), while MRNA has no payments in the available dividend history.
Is BDX or MRNA more profitable?: BDX runs the higher net margin — BDX at 4.52% versus MRNA at -141.43%.
How have BDX and MRNA total returns compared?: Over the past 5 years, BDX delivered 5.12% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BDX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Becton, Dickinson P/E ratio Becton, Dickinson dividend yield Becton, Dickinson ROE Moderna ROE Becton, Dickinson operating margin Moderna operating margin Becton, Dickinson revenue growth Moderna revenue growth Becton, Dickinson free cash flow Moderna free cash flow

Becton, Dickinson & Moderna appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.